Organization
Department of Clinical Data Science
1 abstract
Abstract
Overall survival of patients with BRAF-mutant metastatic colorectal cancer treated with encorafenib-cetuximab in a real-world nationwide study in the Netherlands.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, University Medical Center Utrecht, Utrecht University, Department of Clinical Data Science, Netherlands Comprehensive Cancer Organisation (IKNL),